Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

OXELADIN IMPURITY D CRS (20 MG)

OXELADIN IMPURITY D CRS (20 MG)

NA

DISCOVER
BETAHISTINE DIHYDROCHLORIDE CRS (50 MG)

BETAHISTINE DIHYDROCHLORIDE CRS (50 MG)

5579-84-0

DISCOVER
CLOSANTEL SODIUM DIHYDRATE CRS (20 MG)

CLOSANTEL SODIUM DIHYDRATE CRS (20 MG)

61438-64-0

DISCOVER
CLOSANTEL FOR SYSTEM SUITABILITY CRS (20 MG)

CLOSANTEL FOR SYSTEM SUITABILITY CRS (20 MG)

61438-64-0

DISCOVER
DIPIVEFRINE FOR SYSTEM SUITABILITY CRS (10 MG)

DIPIVEFRINE FOR SYSTEM SUITABILITY CRS (10 MG)

64019-93-8

DISCOVER
GRANISETRON IMPURITY E CRS (15 MG)

GRANISETRON IMPURITY E CRS (15 MG)

135906-03-5

DISCOVER
GRANISETRON HYDROCHLORIDE CRS(120 MG)

GRANISETRON HYDROCHLORIDE CRS(120 MG)

107007-99-8

DISCOVER
LYSINE ACETATE CRS (60 MG)

LYSINE ACETATE CRS (60 MG)

57282-49-2

DISCOVER
METHYL NICOTINATE CRS (25 MG)

METHYL NICOTINATE CRS (25 MG)

93-60-7

DISCOVER
NAPROXEN (RACEMIC) CRS (10 MG)

NAPROXEN (RACEMIC) CRS (10 MG)

23981-80-8

DISCOVER
NALTREXONE HYDROCHLORIDE CRS (50 MG)

NALTREXONE HYDROCHLORIDE CRS (50 MG)

16676-29-2

DISCOVER
PIMOBENDAN FOR SYSTEM SUITABILITY CRS (0.1 MG)

PIMOBENDAN FOR SYSTEM SUITABILITY CRS (0.1 MG)

NA

DISCOVER